Answers are grounded in this paper and cite their sources.
Our results suggest that the chemokine receptor CCR7 is a novel biomarker that can predict lymph node metastases in breast cancer. Utilization of additional markers, such as CXCR4 and HER2-neu, further improves the prediction of the presence and extent of lymph node involvement.
No takes yet. Share an insight, caveat, or question.
Cabıoğlu et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: